Search

everythinglearnresearchcommunity

for

Search:↓

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Neurosteroids show promise for treating epilepsy and more research is needed.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Alopecia patients have less GPER-1, which might affect hair loss.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Hormonal therapies are safe and effective for treating adult women's acne.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Inactive hair follicle stem cells help prevent skin cancer.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Prolactin slows down hair growth in mice.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.